相关实验视频
Updated: Jan 12, 2026

08:06
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
Published on: January 31, 2025
652
后COVID-19无痛甲状腺炎:对甲状腺毒性病管理的案例研究
Siddharth Patel1, William R Norman2, Prutha Pathak3
1Department of Medicine, Decatur Morgan Hospital, Decatur, AL, USA.
The American journal of case reports
|November 4, 2025
概括
无痛甲状腺炎是一种罕见的疾病,可在COVID-19后发生. 本病例报告详细介绍了一名成功治疗COVID-19后无痛甲状腺炎的患者,强调及时诊断和治疗以缓解症状.
科学领域:
- 内分泌学 在内分泌学.
- 病毒学 病毒学
- 内部医学 内部医学
背景情况:
- 无痛甲状腺炎是一种罕见的甲状腺疾病,具有低TSH和正常/高T4,缺乏炎症.
- 甲状腺炎与病毒感染有关,但COVID-19后无痛甲状腺炎并不常见.
研究的目的:
- 在COVID-19之后报告无痛甲状腺炎的病例.
- 突出承认该协会对及时管理的重要性.
主要方法:
- 一个67岁的男性患有COVID-19后症状的病例报告.
- 实验室评估包括TSH,自由T4和抗体检测.
- 无痛甲状腺炎的临床诊断和使用β抑制剂,甲基马和皮质类固醇的治疗.
主要成果:
- 患者在COVID-19后2个月出现了铁毒素症症状.
- 根据低TSH,高的自由T4和负抗体,诊断出无痛的甲状腺炎.
- 随着医疗管理,症状显著改善.
结论:
- 在患有甲状腺毒素症和COVID-19病史的患者中,应考虑COVID-19后无痛甲状腺炎.
- 用β抑制剂,抗甲状腺药物和皮质类固醇及时治疗是有效的.
- 长期监测甲状腺功能低下症是必要的.
相关概念视频
Myocarditis III: Medical Management
168
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
168
Pericarditis III: Medical Management
298
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
298
Myocarditis IV: Nursing Management
203
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
203
Pericarditis IV: Nursing Management
309
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
309
Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
Tonsillitis II: Management
391
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
391

